U.S. markets close in 41 minutes

Awakn Life Sciences Corp. (AWKNF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.8300+0.1354 (+7.99%)
As of 2:54PM EDT. Market open.

Awakn Life Sciences Corp.

5728 East Boulevard
Vancouver, BC V6M 4M4

Full Time Employees18

Key Executives

NameTitlePayExercisedYear Born
Mr. Anthony TennysonCo-founder, Pres, CEO & Director55.24kN/AN/A
Dr. Benjamin Sessa B.Sc., MBBSCo-founder, Chief Medical Officer, Member of Clinical Advisory Board & Director85.53kN/AN/A
Mr. James CollinsChief Operating Officer7.83kN/AN/A
Dr. Shaun McNultyChief Scientific Officer & Member of Pre-Clinical Advisory Board11.57kN/AN/A
Mr. George ScorsisCo-founder & ChairmanN/AN/A1976
Mr. Jonathan James Held C.A., CPA, CACo-founder, CFO & Sec.N/AN/A1986
Prof. David John Nutt DM, FMedSci, FRCP, FRCPsych, FSB, Ph.D.Chair of Pre-Clinical & Clinical Advisory Board and Chief Research OfficerN/AN/AN/A
Prof. Celia MorganHead of Ketamine-Assisted Psychotherapy & Member of Clinical Advisory BoardN/AN/AN/A
Dr. Lowan H. StewartRegional Director of Nordics & MD of Awakn Oslo ASN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company is headquartered in Vancouver, Canada.

Corporate Governance

Awakn Life Sciences Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.